PRACTICAL ONCOLOGY JOURNAL ›› 2013, Vol. 27 ›› Issue (4): 363-366.doi: 10.3969/j.issn.1002-3070.2013.04.015
• Review • Previous Articles Next Articles
WEI Tianli, QU Guofan
Received:
Online:
Published:
Abstract: Osteosarcoma is the most prevalent primary malignant bone tumor in children and teenagers with a poor survival in 40% of the victims.The Wnt/β-catenin signaling pathway has been shown to play a major role in bone cell differentiation, proliferation and apoptosis.It is a critical component of bone mass regulation and required for bone to respond to mechanical loading.The pathway is tightly regulated by a number of modulator proteins.Mutations in pathway components that result in aberrant regulation are involved in a number of bone diseases, especially Osteosarcoma.The use of Wnt pathway associated markers appear promising for osteosarcoma.Drugs targeting the Wnt pathway will gain even more attention.
CLC Number:
R739.96
WEI Tianli, QU Guofan. Recent progress on Wnt pathway and osteosarcoma[J]. PRACTICAL ONCOLOGY JOURNAL, 2013, 27(4): 363-366.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://www.syzlxzz.com/EN/10.3969/j.issn.1002-3070.2013.04.015
http://www.syzlxzz.com/EN/Y2013/V27/I4/363